Company’s head of intellectual property recognized by Intellectual Asset Management as a global IP strategy leader for fifth consecutive year
Image: Headquarters of the United States Patent and Trademark Office. Photo: Courtesy of Coolcaesar at English Wikipedia.
Titan Medical, a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, announces that it has been granted U.S. Patent No. 10,398,287, titled “Camera Positioning System, Method, and Apparatus for Capturing Images During a Medical Procedure.” The patent is directed at aspects of the Company’s innovative dual-view camera system for use in robotic surgery, including single-port robotic surgery.
Titan’s proprietary dual-view camera system consists of an endoscope module that incorporates a flexible 3D high-definition camera along with a light source and a camera insertion tube with an integrated 2D high-definition camera along with an independent light source. This innovative technology provides surgical teams with two high-definition options for visualizing the surgical field, which enhances efficiency and the safety of single-port robotic surgery. The newly granted patent is directed at the endoscope module, including its unique modular and flexible design. This design facilitates convenient camera docking and intra-operative access, providing the ability to clean the primary camera lenses during a surgical procedure without undocking from the robotic surgical system. Additional patent applications directed at other aspects of the dual-view camera system remain pending. With this patent grant and the Company’s latest patent filings, Titan now has 45 patents issued and 82 patent applications.
Titan also announces that Intellectual Asset Management (“IAM”), a leading IP business media platform, named Jasminder Brar, the Company’s Director of Strategic Development and Intellectual Property, to the 2019 edition of IAM Strategy 300: The World’s Leading IP Strategists. This is the fifth consecutive year Mr. Brar has been recognized as a global intellectual property strategy leader.
IAM Strategy 300: The World’s Leading IP Strategists identifies the individuals who are leading the way in the development and implementation of strategies that maximize the value of IP portfolios. Only those individuals identified through a confidential nomination process and who further research shows to have exceptional skill sets, as well as profound insights into the development, creation and management of IP value, are featured in the IAM Strategy 300. Listed in the guide are third-party IP advisers, as well as individuals working inside operating companies, including technology and medical device companies, reflecting the importance that businesses across the world place on in-house IP expertise.
“Titan Medical continues to innovate in single-port robotic surgery, and we are thrilled with the latest patent grant directed at our unique dual-view camera system,” said David McNally, President and CEO of Titan Medical. “We believe our custom-designed visualization technology will provide unique advantages and address some of the current challenges with single-port surgery in particular, and with robotic surgery in general. The strategy behind this latest patent and our overall approach to corporate IP is driven by our in-house expertise, and I’m proud to share the recognition of Jasminder as a leading IP strategist. We are delighted to have him directing our efforts on this extremely important aspect of the Company’s commitment to create value for its stakeholders.”
Source: Company Press Release